sj-docx-1-mdm-10.1177_0272989X231168618 – Supplemental material for A Systematic Review of Methods to Incorporate External Evidence into Trial-Based Survival Extrapolations for Health Technology Assessment

Supplemental material, sj-docx-1-mdm-10.1177_0272989X231168618 for A Systematic Review of Methods to Incorporate External Evidence into Trial-Based Survival Extrapolations for Health Technology Assessment by Ash Bullement, Matthew D. Stevenson, Gianluca Baio, Gemma E. Shields and Nicholas R. Latimer in Medical Decision Making</p

Surrogates of Quality of Life during Double Relapsed and/or Refractory Multiple Myeloma Therapy.

<p>^aAll Surrogates of Quality of Life were recorded from initiation of 1^st DRMM therapy until the end of follow up (or death)</p><p>^bAdverse events with no recorded grade are assumed to be grade 3 or 4.</p><p>Surrogates of Quality of Life during Double Relapsed and/or Refractory Multiple Myeloma Therapy.</p

Kaplan Meier curve showing overall survival, progression free survival and time to treatment failure.

<p>Kaplan Meier curve showing overall survival, progression free survival and time to treatment failure.</p